IDIBELL Seminars: “Aberration of TGF-beta signal transduction in human disease”

Next Friday March 2nd at 13h, the conference hall of the Duran i Reynals Hospital (ICO) holds the seminar “seminari  “Aberration of TGF-beta signal transduction in human disease” by  de Peter Ten Dijke, reserarcher at the Leiden University Medical Centre, The Nederlands.

About Peter Ten Dijke

Peter ten Dijke received his Ph.D. degree in 1991 from Wageningen University, The Netherlands based on his research on the identification of the third isoform of TGF-beta performed at Oncogene Science, Inc, New York, USA. He did his postgraduate studies with Kohei Miyazono and Carl-Henrik Heldin at the Ludwig Institute for Cancer Research (LICR), Uppsala, Sweden. In 1994, he became group leader at LICR and in 1999 he moved to The Netherlands Cancer Institute, Amsterdam, The Netherlands. In 2005 he moved to the Leiden University Medical Center, Leiden, The Netherlands, and is currently a professor of molecular cell biology at Leiden University.

His laboratory studies the molecular mechanisms by which TGF-beta family members elicit their cellular effects via (co)receptors and intracellular SMAD effectors, and how subverted TGF family signaling is involved in cancer, vascular and bone diseases.